For adults with moderate to severe ulcerative colitis (UC) in whom TNF blockers did not work well



For adults with moderate to severe ulcerative colitis (UC) in whom TNF blockers did not work well



How RINVOQ works—know the science

With ulcerative colitis (UC), your immune system mistakenly causes too much inflammation of the colon lining. Over time, uncontrolled inflammation can lead to colon lining damage and UC symptoms.

For moderate to severe UC, your doctor may start you on a TNF blocker such as HUMIRA® or REMICADE®. TNF blockers are injections or infusions that prevent one source of inflammation—excess production of TNF protein in the body. TNF blockers work well for some people, but not for everyone. If your UC is not improving, your doctor may recommend RINVOQ.

RINVOQ is different. RINVOQ is a JAK inhibitor, a drug that targets inflammation caused by a naturally occurring protein called JAK (Janus kinase). RINVOQ works with your body to fight the inflammation that can lead to UC symptoms and colon lining damage.

Because JAK inhibitors, including RINVOQ, affect the immune system, they can lower the ability to fight infections and may cause other serious side effects. It’s important to talk to your healthcare provider about the possible side effects of prescription treatments. Learn more about side effects of RINVOQ.

Jasmine's Story

My doctor had put me on a couple of steroid drugs and injections, and unfortunately they did not work for me.

—JASMINE, moderate to severe UC patient

Interested in learning more about RINVOQ?

People living with UC achieved RINVOQ Results >

Take charge: More topics for you


Meet real RINVOQ patients

Find out what patients have to say about their experience with UC and RINVOQ.

Think beyond symptom relief

Focus on long-term goals such as steroid-free remission and colon lining repair—and what these could mean for you.

REMICADE® (infliximab) is a registered trademark of Janssen Biotech, Inc.